Delivery Order SPE2DB22D2007-SPE2DB25FJ4JG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count) with a ceiling value of $5,275.63. This competitive, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count packaging) with a ceiling value of $7,756.44. This competitively awarded, firm fixed-price delivery order is not associated with any set-aside program and is scheduled for ultimate completion by August 7, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a contract value of $37,834.09. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The contract is scheduled for ultimate completion on September 11, 2025, with performance taking place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dapagliflozin 5 mg tablets in quantities of 30 tablets, valued at $5,141.86 under a firm fixed price contract. This delivery order represents a non-set-aside competitive award and is scheduled for completion by August 11, 2025. The products will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units) valued at $1,605.86. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a routine pharmaceutical supply transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,472.58 with firm fixed pricing and an ultimate completion date of July 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $5,358.11 and a firm fixed price structure. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 25, 2025. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dapagliflozin 10 mg tablets in a 30-count package at a ceiling value of $1,333.77. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $6,100.21 and an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting the federal government's pharmaceutical supply requirements. The order was placed to the company's place of performance in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,998.97 for Dapagliflozin 10 mg tablets (30-count units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single pharmaceutical procurement under the company's existing...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4JGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units) valued at $15,245.22 under a firm fixed price arrangement. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical pharmaceutical supplier to the federal healthcare system. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military and federal healthcare programs, encompassing a broad range of medications, vaccines, medical devices, and specialized healthcare commodities. AmerisourceBergen's extensive federal contract portfolio and demonstrated capability to fulfill diverse medical procurement requirements through open competition position the company as a significant vendor within the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 8/26/25 |